• APHL

    APHL

    Leading the Labs that Protect the Nation’s Health.More.
Our Work

A global leader in lab science, practice and policy, APHL supports member labs and partners with services from training to crisis response.


Featured Resources

 

 

Leading Informaticshttp://redesign.dev.aphl.org/leadership/Lists/Highlighted Content/DispForm.aspx?ID=2Leading Informatics<img alt="" src="/PublishingImages/Leadership%203.gif" style="BORDER:0px solid;" />http://redesign/programs/informatics/Pages/default.aspx, http://redesign.dev.aphl.org/programs/informatics/Pages/default.aspx
Offering Babies NewSTEPs http://redesign.dev.aphl.org/leadership/Lists/Highlighted Content/DispForm.aspx?ID=1Offering Babies NewSTEPs <img alt="" src="/PublishingImages/Leadership%202.gif" style="BORDER:0px solid;" />http://redesign/programs/newborn_screening/Pages/NewSTEPs.aspx, http://redesign.dev.aphl.org/programs/newborn_screening/Pages/NewSTEPs.aspx
Building Lab Systemshttp://redesign.dev.aphl.org/leadership/Lists/Highlighted Content/DispForm.aspx?ID=3Building Lab Systems<img alt="" src="/PublishingImages/Leadership%204.gif" style="BORDER:0px solid;" />http://redesign/consulting/Pages/default.aspx, http://redesign.dev.aphl.org/consulting/Pages/default.aspx

 

 

2015 All-Hazards Survey Reporthttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/PHPR-2015-All-Hazards-52016-digital.pdf2015 All-Hazards Survey ReportEach year, APHL surveys PHLs to assess their readiness to respond to threats and identify challenges that affect rapid response. This year's survey covers the 12-month period from 7/1/14 - 6/30/15, representing FY14 CDC PHEP Cooperative Agreement, BP 3.
Guidance for State Medical Cannabis Testinghttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/EH-Guide-State-Med-Cannabis-052016.pdfGuidance for State Medical Cannabis Testing
MTBC Drug Susceptibility Testing: EMBhttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/ID-MTBC_DrugSusceptibility_0216.pdfMTBC Drug Susceptibility Testing: EMBA discussion of issues surrounding the use of the anti-tuberculosis drug Ethambutol, or EMB, including recommended dose, EMB drug susceptibility testing and test methods, and reproducibility of susceptibility testing for EMB.
MTBC Drug Susceptibility Testing: PZAhttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/ID-PZA_WhitePaper_0216.pdfMTBC Drug Susceptibility Testing: PZAA discussion about the use of Pyrazinimide, or PZA, as first-line therapy for treatment of Mycobacterium tuberculosis complex, including mechanism of action, reproducibility of susceptibility testing, and impact on clinical outcomes.